Business description: ResMed, Inc.

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:

- medical devices (50.4%);

- masks (37.9%);

- software as a service (11.7%).

At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.

The United States accounts for 61.4% of net sales.

Number of employees: 9,980

Sales by Activity: ResMed, Inc.

Fiscal Period: June20202021202220232024

Sleep and Breathing Health

260.24Cr 282.32Cr 317.73Cr 372.5Cr 410.12Cr

Residential Care Software

35Cr 37Cr 40Cr 50Cr 58Cr
See all business segments

Geographical breakdown of sales: ResMed, Inc.

Fiscal Period: June20202021202220232024

United States

182.86Cr 196.27Cr 224.94Cr 271.99Cr 298.01Cr

Rest of The World

112.84Cr 123.41Cr 132.87Cr 150.31Cr 170.52Cr
See all geographic segments

Executive Committee: ResMed, Inc.

Manager TitleAgeSince
Chief Executive Officer 52 01/03/2013
Director of Finance/CFO 58 01/01/2006
Compliance Officer - 01/01/2018
Chief Tech/Sci/R&D Officer - 03/01/2017
Investor Relations Contact - 21/04/2025
See RESMED, INC. governance

Composition of the Board of Directors: ResMed, Inc.

Director TitleAgeSince
Director/Board Member 75 25/08/2005
Director/Board Member 77 01/01/2005
Chairman 52 25/01/2023
Chairman 82 01/06/1989
Director/Board Member 67 01/11/2013
Director/Board Member 65 17/11/2017
Director/Board Member 60 15/11/2018
Director/Board Member 60 16/05/2019
Director/Board Member 58 18/11/2021
Director/Board Member 49 18/11/2021
Composition of the Board of Directors

Shareholders: ResMed, Inc.

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
12.59 %
1,84,93,702 12.59 % 4 771 M $
BlackRock Advisors LLC
6.984 %
1,02,57,799 6.984 % 2 647 M $
4.461 %
65,51,404 4.461 % 1 690 M $
BNY Mellon Investment Adviser, Inc.
3.544 %
52,04,321 3.544 % 1 343 M $
Eaton Vance Management
2.819 %
41,39,611 2.819 % 1 068 M $
NameEquities%Valuation
Australian Foundation Investment Co. Ltd. (Invt Mgmt)
0.3978 %
58,41,989 0.3978 % 151 M $
AllianceBernstein Investments Taiwan Ltd.
0.3185 %
46,77,300 0.3185 % 121 M $
BetaShares Capital Ltd.
0.2899 %
42,57,831 0.2899 % 110 M $
Australian United Investment Co. Ltd. (Investment Management)
0.1158 %
17,00,000 0.1158 % 44 M $
Russell Investment Management Ltd.
0.1131 %
16,61,002 0.1131 % 43 M $
List of RESMED, INC. shareholders

Holdings: ResMed, Inc.

NameEquities%Valuation
17,27,864 5.02% 1,30,82,229 $

Company details: ResMed, Inc.

ResMed, Inc.

9001 Spectrum Center Boulevard

92123, San Diego

+858-836-5000

http://www.resmed.com
address ResMed, Inc.(RMD)

Group companies: ResMed, Inc.

NameCategory and Sector
Medical Specialties
Medical/Nursing Services
Medical Specialties
See all subsidiaries

Other Advanced Medical Equipment & Technology

Change 5d. change 1-year change 3-years change Capi.($)
+0.85%-0.64%+24.51%+13.71% 3.72TCr
+0.69%-1.88%+21.10%+144.72% 18TCr
+2.08%-1.33%-23.44%-21.13% 16TCr
+1.41%+0.76%+35.19%+178.70% 15TCr
+0.77%-5.22%-22.47%-23.84% 14TCr
+1.04%-2.63%-13.30%-3.98% 6TCr
+0.05%-3.32%-12.75%-23.38% 4.47TCr
+1.18%-0.67%-22.71%-31.50% 3.61TCr
+1.05%-0.34%-7.55% - 3.45TCr
+2.58%-6.29%-12.84%-2.08% 3.22TCr
Average +0.78%-2.26%-3.43%+25.69% 8.77TCr
Weighted average by Cap. +0.80%-2.02%+0.58%+53.76%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
256.42USD
Average target price
269.49USD
Spread / Average Target
+5.10%
Consensus

Quarterly revenue - Rate of surprise